Top research reports highlight positive factors for Amazon, Stryker, and Lam Research

From Nasdaq: 2024-12-03 16:27:00

In today’s Zacks Research Daily, reports on 16 major stocks are featured, including Amazon.com, Inc. (AMZN), Stryker Corp. (SYK) and Lam Research Corp. (LRCX). Amazon’s shares have outperformed the industry, thanks to its growing global presence and focus on generative AI. Stryker’s strong international sales and order book are positives, but inflation and competition pose challenges. Lam Research is benefiting from its advanced technologies, but US-China tensions are a concern. Immucell faces hurdles due to high costs and competition, despite sales growth from First Defense.

Duke Energy Corp. (DUK), Aon plc (AON), and HCA Healthcare, Inc. (HCA) are also covered. Duke Energy’s investments in infrastructure are driving growth, but its financial position remains a concern. Aon’s strategic acquisitions are boosting profit growth, but rising debts are a worry. HCA Healthcare’s revenue growth from increasing admissions and acquisitions is significant.

The Zacks analyst notes that Axsome Pharmaceuticals’ (AXSM) lead drug, Auvelity, and Sunosi are driving sales, despite competition. Broadridge Financial Solutions, Inc. (BR) benefits from the Itiviti acquisition, but faces competition. Carvana Co. (CVNA) is seeing margin growth from cost-containment initiatives.

Silicon Motion Technology Corp. (SIMO) is facing profitability challenges from macroeconomic headwinds and integration risks. Arrow Electronics, Inc. (ARW) is hurt by cyclical headwinds and unfavorable forex. Leggett & Platt, Inc. (LEG) is witnessing weak demand due to a challenging macro environment.

Zacks offers a special $1 deal for access to all picks, including Surprise Trader and Stocks Under $10, which closed 228 positions with double- and triple-digit gains in 2023. Click to see all stocks now.



Read more at Nasdaq: Top Research Reports for Amazon, Stryker & Lam Research